Patrick John Jermain Sells 3,361 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) CFO Patrick John Jermain sold 3,361 shares of the company’s stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $144.57, for a total value of $485,899.77. Following the completion of the sale, the chief financial officer now owns 20,745 shares in the company, valued at approximately $2,999,104.65. This represents a 13.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Patrick John Jermain also recently made the following trade(s):

  • On Wednesday, November 6th, Patrick John Jermain sold 2,643 shares of Plexus stock. The shares were sold at an average price of $166.32, for a total value of $439,583.76.

Plexus Price Performance

Shares of PLXS stock traded down $1.11 during trading hours on Wednesday, reaching $143.42. 165,120 shares of the company were exchanged, compared to its average volume of 182,440. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $172.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.71. The stock’s fifty day moving average is $161.76 and its two-hundred day moving average is $142.70. The company has a market cap of $3.89 billion, a price-to-earnings ratio of 33.28 and a beta of 0.91.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.43%. Sell-side analysts forecast that Plexus Corp. will post 6.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on PLXS shares. Stifel Nicolaus upped their target price on shares of Plexus from $136.00 to $150.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Benchmark reaffirmed a “buy” rating and set a $165.00 price objective on shares of Plexus in a report on Wednesday, January 22nd. KeyCorp initiated coverage on shares of Plexus in a research note on Tuesday, October 22nd. They issued a “sector weight” rating for the company. StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, Needham & Company LLC lifted their price objective on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Plexus currently has a consensus rating of “Moderate Buy” and a consensus price target of $162.33.

Check Out Our Latest Analysis on PLXS

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Mercer Global Advisors Inc. ADV raised its stake in shares of Plexus by 6.7% during the second quarter. Mercer Global Advisors Inc. ADV now owns 2,788 shares of the technology company’s stock worth $288,000 after buying an additional 176 shares during the last quarter. Bank of Montreal Can raised its position in shares of Plexus by 148.7% during the 2nd quarter. Bank of Montreal Can now owns 11,049 shares of the technology company’s stock valued at $1,147,000 after acquiring an additional 6,606 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of Plexus by 2.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,864 shares of the technology company’s stock valued at $1,534,000 after purchasing an additional 384 shares during the period. Scientech Research LLC bought a new position in shares of Plexus in the 2nd quarter worth $347,000. Finally, Algert Global LLC acquired a new stake in shares of Plexus during the second quarter worth $287,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.